Todd Catherine S, Ahmadzai Malalay, Atiqzai Faridullah, Miller Suellen, Smith Jeffrey M, Ghazanfar Syed Alef Shah, Strathdee Steffanie A
Division of International Health & Cross-Cultural Medicine, University of California, San Diego, La Jolla, California, USA.
BMC Infect Dis. 2008 Sep 17;8:119. doi: 10.1186/1471-2334-8-119.
Little current information is available for prevalence of vertically-transmitted infections among the Afghan population. The purpose of this study is to determine prevalence and correlates of human immunodeficiency virus (HIV), syphilis, and hepatitis B and C infection among obstetric patients and model hepatitis B vaccination approaches in Kabul, Afghanistan.
This cross-sectional study was conducted at three government maternity hospitals in Kabul, Afghanistan from June through September, 2006. Consecutively-enrolled participants completed an interviewer-administered survey and whole blood rapid testing with serum confirmation for antibodies to HIV, T. pallidum, and HCV, and HBsAg. Descriptive data and prevalence of infection were calculated, with logistic regression used to identify correlates of HBV infection. Modeling was performed to determine impact of current and birth dose vaccination strategies on HBV morbidity and mortality.
Among 4452 women, prevalence of HBsAg was 1.53% (95% CI: 1.18 - 1.94) and anti-HCV was 0.31% (95% CI: 0.17 - 0.53). No cases of HIV or syphilis were detected. In univariate analysis, HBsAg was associated with husband's level of education (OR = 1.13, 95% CI: 1.01 - 1.26). Modeling indicated that introduction of birth dose vaccination would not significantly reduce hepatitis-related morbidity or mortality for the measured HBsAg prevalence.
Intrapartum whole blood rapid testing for HIV, syphilis, HBV, and HCV was acceptable to patients in Afghanistan. Though HBsAg prevalence is relatively low, periodic assessments should be performed to determine birth dose vaccination recommendations for this setting.
目前关于阿富汗人群中垂直传播感染的流行情况的信息很少。本研究的目的是确定阿富汗喀布尔产科患者中人类免疫缺陷病毒(HIV)、梅毒、乙型和丙型肝炎感染的流行情况及其相关因素,并建立乙型肝炎疫苗接种方法模型。
这项横断面研究于2006年6月至9月在阿富汗喀布尔的三家政府妇产医院进行。连续招募的参与者完成了一份由访谈员进行的调查,并进行了全血快速检测,血清确认HIV、梅毒螺旋体、丙型肝炎病毒抗体和乙肝表面抗原。计算描述性数据和感染率,采用逻辑回归确定乙肝感染的相关因素。进行建模以确定当前和出生剂量疫苗接种策略对乙肝发病率和死亡率的影响。
在4452名妇女中,乙肝表面抗原的流行率为1.53%(95%可信区间:1.18 - 1.94),抗丙型肝炎病毒抗体流行率为0.31%(95%可信区间:0.17 - 0.53)。未检测到HIV或梅毒病例。单因素分析显示,乙肝表面抗原与丈夫的教育程度相关(比值比 = 1.13,95%可信区间:1.01 - 1.26)。建模表明,引入出生剂量疫苗接种不会显著降低所测乙肝表面抗原流行率下的肝炎相关发病率或死亡率。
在阿富汗,患者接受产时全血快速检测HIV、梅毒、乙肝和丙肝。尽管乙肝表面抗原流行率相对较低,但应定期进行评估,以确定该环境下的出生剂量疫苗接种建议。